版本:
中国

U.S. states sue opioid-maker Indivior over alleged anticompetitive practices

WASHINGTON, Sept 22 Thirty-five U.S. states and the District of Columbia filed a lawsuit on Thursday against opioid drug maker Indivior alleging it tried to keep generic versions of a drug off the market.

British-based Indivior, which was spun off from Reckitt Benckiser in 2014, is the maker of Suboxone, a drug used to treat patients addicted to heroin and other painkillers.

The lawsuit by the states alleged that Indivior took steps to get patients to switch to a dissolvable oral strip version of Suboxone.

(Reporting by Sarah N. Lynch; Editing by Peter Cooney)

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐